Phenobarbital promotes liver growth in c-myc/TGF-α transgenic mice by inducing hypertrophy and inhibiting apoptosis

Carcinogenesis

Volumn 20, Issue 1, 1999, Pages 41-49

  Sanders, Sean ^a   Thorgeirsson, Snorri S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHENOBARBITAL; PROTEIN BCL 2; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; TUMOR PROMOTER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; LIVER HYPERTROPHY; LIVER TUMOR; MITOSIS INDEX; MOUSE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; TRANSGENIC MOUSE; TUMOR PROMOTION;

ANIMALS; APOPTOSIS; BCL-X PROTEIN; CARCINOGENS; CELL DIVISION; DIET; GENE EXPRESSION REGULATION; GENES, BCL-2; GENES, MYC; HYPERTROPHY; LIVER; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, TRANSGENIC; ORGAN SIZE; PHENOBARBITAL; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, GROWTH FACTOR; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032896953     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.1.41     Document Type: Article

References (62)

1. Peraino, C., Fry, R.J.M. and Staffeldt, E. (1971) Reduction and enhancement by phenobarbital of hepatocarcinogenesis induced in the rat by 2-acetylaminofluorene. Cancer Res., 31, 1506-1512.
2. Peraino, C., Fry, R.J.M. and Staffeldt, E. (1973) Enhancement of spontaneous hepatic tumorigenesis in C3H mice by dietary phenobarbital. J. Natl Cancer Inst., 51, 1349-1350.
3. Clemmesen, J. and Hjalgrim-Jensen, S. (1978) Is phenobarbital carcinogenic? A follow-up of 8078 epileptics. Ecotoxicol. Environ. Safety, 1, 457-470.
4. Jirtle, R.L., Meyer, S.A. and Brockenbrough, J.S. (1991) Liver tumor promoter phenobarbital: a biphasic modulator of hepatocyte proliferation. Prog. Clin. Biol. Res., 369, 209-216.
5. Peraino, C., Fry, R.J., Staffeldt, E. and Christopher, J.P. (1975) Comparative enhancing effects of phenobarbital, amobarbital, diphenylhydantoin and dichlorodiphenyltrichloroethane on 2-acetylaminofluorene-induced hepatic tumorigenesis in the rat. Cancer Res., 35, 2884-2890.
6. Eckl, P.M., Meyer, S.A., Whitcombe, W.R. and Jirtle, R.L. (1988) Phenobarbital reduces EGF receptors and the ability of physiological concentrations of calcium to suppress hepatocyte proliferation. Carcinogenesis, 9, 479-483.
7. Tsai, W.-H. and DeAngelo, A.B. (1996) Responsiveness of hepatocytes from dichloroacetic acid or phenobarbital treated mice to growth factors in primary cultures. Cancer Lett., 99, 177-183.
8. Jirtle, R.L. and Meyer, S.A. (1991) Liver tumor promotion: effect of phenobarbital on EGF and protein kinase C signal transduction and transforming growth factor-β1 expression. Dig. Dis. Sci., 36, 659-668.
9. Tsai, W.-H. and Michalopoulos, G.K. (1991) Responsiveness of hepatocytes to epidermal growth factor, transforming growth factor-beta and norepinephrine during treatment with xenobiotic tumor promoters. Cancer Lett., 57, 83-90.
10. Tsai, W.-H., Zarnegar, R. and Michalopoulos, G.K. (1991) Long-term treatment with hepatic tumor promoters inhibits mitogenic responses of hepatocytes to acidic fibroblast growth factor and hepatocyte growth factor. Cancer Lett., 59, 103-108.
11. Brockenbrough, J.S., Meyer, S.A., Li, C. and Jirtle, R.L. (1991) Reversible and phorbol ester-specific defect of protein kinase C translocation in hepatocytes isolated from phenobarbital-treated rats. Cancer Res., 51, 130-136.
12. Schulte-Hermann, R. and Timmermann-Trosiener, I. (1984) Aberrant Expression of Adaptation to Phenobarbital May Cause Selective Growth of Foci of Altered Cells in Rat Liver. IARC Scientific Publications no. 56, IARC, Lyon, pp. 67-75.
13. Aubrecht, J., Hirsch-Ernst, K.I., Becker-Rabbenstein, V., Kahl, G.F., Taniguchi, H. and Hohne, M.W. (1995) Induction of cytochrome P-4502B1-related mouse cytochrome P-450 and regulation of its expression by epidermal growth factor/transforming growth factor alpha in primary hepatocyte culture. Biochem. Pharmacol., 50, 781-785.
14. Guppy, M.J., Wilton, J.C., Sharma, R., Coleman, R. and Chipman, J.K. (1994) Modulation of phenbarbitone-induced loss of gap junctional intercellular communication in hepatocyte couplets. Carcinogenesis, 15, 1917-1921.
15. McClain, R.M., Levin, A.A., Posch, R. and Downing, J.C. (1989) The effect of phenobarbital on the metabolism and excretion of thyroxine in rats. Toxicol. Appl. Pharmacol., 99, 216-228.
16. McClain, R.M. (1989) The significance of hepatic microsomal enzyme induction and altered thyroid function in rats: implications for thyroid gland neoplasia. Toxicol. Pathol., 17, 294-306.
17. Wörner, W. and Schrenk, D. (1996) Influence of liver tumor promoters on apoptosis in rat hepatocytes induced by 2-acetylaminofluorene, ultraviolet light, or transforming growth factor β1. Cancer Res., 56, 1272-1278.
18. Bursch, W., Lauer, B., Timmermann-Trosiener, I., Barthel, G., Schuppler, J. and Schulte-Hermann, R. (1984) Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters. Carcinogenesis, 5, 453-458.
19. Schulte-Hermann, R., Timmermann-Trosiener, I., Barthel, G. and Bursch, W. (1990) DNA synthesis, apoptosis and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion. Cancer Res., 50, 5127-5135.
20. Schulte-Hermann, R. and Bursch, W. (1995) Apoptosis and hepatocarcinogenesis. In Jirtle, R.L. (ed.) Liver Regeneration and Carcinogenesis: Molecular and Cellular Mechanisms. Academic Press, San Diego, CA, pp. 141-178.
21. Kaufmann, W.K., Byrd, L.L., Palmieri, D., Nims, R.W. and Rice, J.M. (1997) TGF-α sustains clonal expansion by promoter-dependent, chemically initiated rat hepatocytes. Carcinogenesis, 18, 1381-1387.
22. Santoni-Rugiu, E., Jensen, M.R. and Thorgeirsson, S.S. (1998) Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor α. Cancer Res., 58, 123-134.
23. Sandgren, E.P., Schroeder, J.A., Qui, T.H., Palmiter, R.D., Brinster, R.L. and Lee, D.C. (1995) Inhibition of mammary gland involution is associated with transforming growth factor α but not c-myc-induced tumorigenesis in transgenic mice. Cancer Res., 55, 3915-3929.
24. Smith, G., Sharp, R., Kordon, E.C., Jhappen, C. and Merlino, G. (1995) Transforming growth factor-α promotes mammary tumorigenesis through selective survival and growth of secretory epithelial cells. Am. J. Pathol., 147, 1081-1096.
25. Murakami, H., Sanderson, N., Nagy, P., Marino, P.A., Merlino, G. and Thorgeirsson, S.S. (1993) Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor a in hepatic oncogenesis. Cancer Res., 53, 1719-1723.
26. Santoni-Rugiu, E., Nagy, P., Jensen, M.R., Factor, V.M. and Thorgeirsson, S.S. (1996) Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-α. Am. J. Pathol., 149, 407-428.
27. Jhappen, C., Stahle, C., Jarkins, R.N., Fausto, N., Smith, G.H. and Merlino, G.T. (1990) TGFα overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell, 61, 1137-1146.
28. Böhm, N. and Moser, B. (1976) Reversible hyperplasia and hypertrophy of the mouse liver induced by a functional charge with phenobarbital (in German). Beitr. Pathol., 157, 283-300.
29. Krajewski, S., Krajewska, M., Shabaik, A., Miyashita, T., Wang, H.G. and Reed, J.C. (1994) Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am. J. Pathol., 145, 1323-1336.
30. Flanders, K., Thompson, N., Cissel, D., Van Obberghen-Schilling, E., Baker, C., Kass, M., Ellingsworth, L., Roberts, A. and Sporn, M. (1989) Transforming growth factor-β1: histochemical localization with antibodies to different epitopes. J. Cell Biol., 108, 653-660.
31. Santoni-Rugiu, E., Preisegger, K.H., Kiss, A., Audolfsson, T., Shiota, G., Schmidt, E.V. and Thorgeirsson, S.S. (1996) Inhibition of neoplastic development in the liver by hepatocyte growth factor in a transgenic mouse model. Proc. Natl Acad. Sci. USA, 93, 9577-9582.
32. Sargent, L.M., Sanderson, N. and Thorgeirsson, S.S. (1996) Ploidy and karyotic alterations associated with early events in the development of hepatocarcinogenesis in transgenic mice harboring c-myc and transforming growth factor α transgenes. Cancer Res., 56, 2137-2142.
33. Factor, V.M., Jensen, M.R. and Thorgeirsson, S.S. (1997) Coexpression of c-myc and transforming growth factor-alpha in the liver promotes early replicative senescence and diminishes regenerative capacity after partial hepatectomy in transgenic mice. Hepatology, 26, 1434-1443.
34. Bursch, W., Taper, H.S., Lauer, B. and Schulte-Hermann, R. (1985) Quantitative histological and histochemical studies on the occurrence and stages of controlled cell death (apoptosis) during regression of rat liver hyperplasia. Virchows Arch. B Cell. Pathol. Incl. Mol. Pathol., 50, 153-166.
35. Kolaja, K.L., Stevenson, D.E., Walborg, E.F. Jr and Klaunig, J.E. (1996) Dose dependence of phenobarbital promotion of preneoplastic hepatic lesions in F344 rats and B6C3F1 mice: effects on DNA synthesis and apoptosis. Carcinogenesis, 17, 947-954.
36. Amundadottir, L.T., Nass, S.J., Berchem, G.J., Johnson, M.D. and Dickson, R.B. (1996) Cooperation of TGF-α and c-Myc in mouse mammary tumorigenesis: coordinated stimulation of growth and suppression of apoptosis. Oncogene, 13, 757-765.
37. Takagi, H., Sharp, R., Takayama, H., Anver, M.R., Ward, J.M. and Merlino, G. (1993) Collaboration between growth factors and diverse chemical carcinogens in hepatocarcinogenesis of transforming growth factor α transgenic mice. Cancer Res., 53, 4329-4336.
38. Shimizu, S., Eguchi, Y., Kamiike, W., Waguri, S., Uchiyama, Y., Matsuda, H. and Tsujimoto, Y. (1996) Retardation of chemical hypoxia-induced necrotic cell death by bcl-2 and ICE inhibitors: possible involvement of common mediators in apoptotic and necrotic signal transductions. Oncogene, 12, 2045-2050.
39. Eguchi, Y., Shimizu, S. and Tsujimoto, Y. (1997) Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res., 57, 1835-1840.
40. Chiao, C., Zhang, Y., Kaufman, D.G. and Kaufmann, W.K. (1995) Derivation of phenobarbital-responsive immortal rat hepatocytes. Am. J. Pathol., 146, 1248-1259.
41. Chiao, C., Zhang,Y., Kaufman, D.G. and Kaufmann, W.K. (1995) Phenobarbital modulates the type of cell death in rat hepatocytes during deprivation of serum in vitro. Hepatology, 22, 297-303.
42. Columbano, A. (1995) Cell death: current difficulties in discriminating apoptosis from necrosis in the context of pathological processes in vivo. J. Cell. Biochem., 58, 181-190.
43. Trump, B.F., Berezesky, I.K., Chang, S.H. and Phelps, P.C. (1997) The pathways of cell death: oncosis, apoptosis and necrosis. Toxicol. Pathol., 25, 82-88.
44. Majno, G. and Joris, I. (1995) Apoptosis, oncosis and necrosis: an overview of cell death. Am. J. Pathol., 146, 3-14.
45. Mansbach, J.M., Mills, J.J., Boyer, I.J., De Souza, A.T., Hankins, G.R. and Jirtle, R.L. (1996) Phenobarbital selectively promotes initiated cells with reduced TGFβ receptor levels. Carcinogenesis, 17, 171-174.
46. Reisenbichler, H., Chari, R.S., Boyer, I.J. and Jirtle, R.L. (1994) Transforming growth factor-β receptors type I, II and III in phenobarbital-promoted rat liver tumors. Carcinogenesis, 15, 2763-2767.
47. Chen, C.Y. and Faller, D.V. (1996) Phosphorylation of Bcl-2 protein and association with p21Ras in Ras-induced apoptosis. J. Biol. Chem., 271, 2376-2379.
48. Ito, T., Deng, X., Carr, B. and May, W.S. (1997) Bcl-2 phosphorylation required for anti-apoptosis function. J. Biol. Chem., 272, 11671-11673.
49. Haldar, S., Jena, N. and Croce, C.M. (1995) Inactivation of Bcl-2 by phosphorylation. Proc. Natl Acad. Sci. USA, 92, 4507-4511.
50. Blagosklonny, M.V., Schulte, T., Nguyen, P., Trepel, J. and Neckers, L.M. (1996) Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway. Cancer Res., 56, 1851-1854.
51. Blagosklonny, M.V., Giannakakou, P., El-Deiry, W.S., Kingston, D.G., Higgs, P.I., Neckers, L. and Fojo, T. (1997) Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death. Cancer Res., 57, 130-135.
52. Maundrell, K., Antonsson, B., Magnenat, E. et al. (1997) Bcl-2 undergoes phosphorylation by c-Jun N-terminal kinase/stress-activated protein kinases in the presence of the constitutively active GTP-binding protein Rac1. J. Biol. Chem., 272, 25238-25242.
53. L during apoptosis. Proc. Natl Acad. Sci. USA, 94, 3668-3572.
54. Wolter, K.G., Hsu, Y.-T., Smith, C.L., Nechushtan, A. and Xi, X.-G. (1997) Movement of Bax from the cytosol to mitochondria during apoptosis. J. Cell Biol., 139, 1281-1292.
55. Reed, J.C. (1994) Bcl-2 and the regulation of programmed cell death. J. Cell Biol., 124, 1-6.
56. Kluck, R.M., Bossy-Wetzel, E., Green, D.R. and Newmeyer, D.D. (1997) The release of cytochrome c from mitochondria: a primary site for bcl-2 regulation of apoptosis. Science, 275, 1132-1136.
57. Reed, J.C. (1997) Double identity for proteins of the Bcl-2 family. Nature, 387, 773-776.
58. Yang, J., Liu, X., Bhalla, K., Kim, C.N., Ibrado, A.M., Cai, J., Peng, T.-I., Jones, D.P. and Wang, X. (1997) Prevention of apoptosis by bcl-2: release of cytochrome c from mitochondria blocked. Science, 275, 1128-1132.
59. Rossé, T., Olivier, R., Monney, L., Rager, M., Conus, S., Fellay, I., Jansen, B. and Borner, C. (1998) Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c. Nature, 391, 496-499.
60. Li, Y., Leung, L.K., Spear, B.T. and Glauert, H.P. (1996) Activation of hepatic NF-κB by phenobarbital in rats. Biochem. Biophys. Res. Commun., 229, 982-989.
61. Attar, R.M., Caamaño, J., Carrasco, D., Iotsova, V., Ishikawa, H., Ryseck, R.-P., Weih, F. and Bravo, R. (1997) Genetic approaches to study Rel/NF-kappa B/I kappa B function in mice. Semin. Cancer Biol., 8, 93-101.
62. Grimm, S., Bauer, M.K.A., Baeuerle, P.A. and Schulze-Osthoff, K. (1996) Bcl-2 down-regulates the activity of transcription factor NF-κ-B induced upon apoptosis. J. Cell Biol., 134, 13-23.